Consano Bio, Inc.

New Filing

CIK: 0001981285·Biotechnology·DELAWARE·Filed: Dec 12, 2025

Total Offering

$16,840,000

Amount Sold

$16,840,000

Investors

18

First Sale

Oct 15, 2024

Offering Details

Type: Debt, Security to be Acquired
Exemptions: Rule 506(b)

Related Persons

Name	Role
Andrew Hall	Executive Officer, Director
Jennifer Schmitke	Executive Officer
Doug Vander Weide	Director
Chris Centeno	Director
Bill Abbington	Director
Jerome Adams	Director

Company

CONSANO BIOLOGICS, LLC

100 SUMMIT DRIVE

BURLINGTON, MA, 01803

617-798-4559

SEC Filing

0001981285-25-000005

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.